| 注册
首页|期刊导航|亚太传统医药|中药及有效成分多靶点干预肥胖症研究进展

中药及有效成分多靶点干预肥胖症研究进展

金玉秀 罗亚锋 孙会锦 王学英

亚太传统医药2025,Vol.21Issue(11):232-238,7.
亚太传统医药2025,Vol.21Issue(11):232-238,7.DOI:10.11954/ytctyy.202511044

中药及有效成分多靶点干预肥胖症研究进展

The Research Progress of Multi-Target Intervention in Obesity with Traditional Chinese Medicine and Its Active Components

金玉秀 1罗亚锋 2孙会锦 1王学英3

作者信息

  • 1. 湖北中医药大学,湖北武汉 430065
  • 2. 襄阳市中医医院,湖北襄阳 441099
  • 3. 惠水县中医医院,贵州 黔南布依族苗族自治州 558000
  • 折叠

摘要

Abstract

Obesity has become a global health challenge.Although Western medicine is highly effective in weight loss,it carries risks such as gastrointestinal reactions,pancreatitis,and retinopathy.Traditional Chinese materia medica has the advantages of multi-target and minimal side effects.Experimental results show that the pathogenesis of obesity involves multiple pathways,including disruption of gut microbiota(elevated F/B ratio),chronic inflammation(increased inflam-matory cytokines such as TNF-α and IL-6),neuroendocrine disorders(mutations,deletions,and dysregulation within the GPCRs family),and abnormal fat metabolism(reduced UCP1 expression),among multiple pathways.Active com-ponents of Chinese materia medica(such as alkaloids,flavonoids,polysaccharides,glycosides,etc.)exert weight-reduc-ing effects through mechanisms including regulating gut microbiota,improving neuroregulation,promoting fat brown-ing,and inhibiting inflammatory responses.Studies show that Chinese materia medica of the types of diuretic and phlegm-resolving,heat-clearing and phlegm-transforming,spleen and kidney tonifying,and blood-activating and Qi-regulating,through syndrome differentiation and treatment,target different types of obesity,collectively regulating ap-petite,lipid metabolism,and energy expenditure through multiple pathways involving the intestine,neuroendocrine,and fat.Chinese materia medica and its active components provide a new strategy for the treatment of obesity through a multi-target regulation mechanism via the intestine,neuroendocrine,and fat.

关键词

肥胖症/中药及有效成分/多靶点干预/研究进展

Key words

Obesity/Chinese Materia Medica and Its Active Ingredients/Multi-Target Intervention/Research Progress

分类

医药卫生

引用本文复制引用

金玉秀,罗亚锋,孙会锦,王学英..中药及有效成分多靶点干预肥胖症研究进展[J].亚太传统医药,2025,21(11):232-238,7.

亚太传统医药

1673-2197

访问量0
|
下载量0
段落导航相关论文